Life sciencesAlternativesEast of EnglandLondonSouth EastUK & Ireland
11 Apr 2022 | 08:03 BST | by Lovelyn Tagalag
Around 83% of investments in life science start-ups went into firms in London, the South East and East
Want to read the full article?
InterRent JV buys Montréal apartments for $107m
First phase of Swansea Central regeneration secures approval
Colliers appoints new head of strategy, data and innovation
LaSalle agrees £123m loan for UK holiday parks acquisition
Center Parcs to develop £450m Scottish holiday village
Hong Kong investor inks £127m St James’s sale
Flex provider takes space at W.RE’s Clapham Junction office
Investors sought for planned billion-dollar senior-housing portfolio in GTA
PLP appoints head of investment management
Land up for grabs in Vancouver’s Mount Pleasant for $20m
